Home/Filings/4/0001209191-21-024707
4//SEC Filing

Walkey Carl 4

Accession 0001209191-21-024707

CIK 0001404644other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:21 PM ET

Size

5.5 KB

Accession

0001209191-21-024707

Insider Transaction Report

Form 4
Period: 2021-03-31
Walkey Carl
Senior Vice President
Transactions
  • Sale

    Common Stock

    2021-03-31$11.96/sh1,800$21,5281,366,162 total
Footnotes (2)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $11.94 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Issuer

Neoleukin Therapeutics, Inc.

CIK 0001404644

Entity typeother

Related Parties

1
  • filerCIK 0001843189

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:21 PM ET
Size
5.5 KB